| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 0 | 0 | 0 | 8.657 | 18.834 | 9.205 |
| Total Income - EUR | - | - | - | 0 | 0 | 0 | 0 | 8.657 | 18.834 | 9.205 |
| Total Expenses - EUR | - | - | - | 4 | 233 | 165 | 162 | 1.483 | 1.370 | 1.544 |
| Gross Profit/Loss - EUR | - | - | - | -4 | -233 | -165 | -162 | 7.174 | 17.464 | 7.661 |
| Net Profit/Loss - EUR | - | - | - | -4 | -233 | -165 | -162 | 6.920 | 14.767 | 6.444 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Lumiderma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 22 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 43 | 42 | 41 | 40 | 7.153 | 15.962 | 7.728 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 0 | 0 | 0 | 3.175 | 9.679 | 6.136 |
| Cash | - | - | - | 43 | 42 | 41 | 40 | 3.978 | 6.282 | 1.592 |
| Shareholders Funds | - | - | - | 39 | -196 | -357 | -511 | 6.407 | 14.815 | 6.493 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 26 | 238 | 399 | 551 | 746 | 1.146 | 1.235 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Lumiderma S.r.l.